Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Orthopaedic Surgery and Research
Published in: Journal of Orthopaedic Surgery and Research 1/2019

Open Access 01-12-2019 | Injectable Filler | Research article

Early postoperative compilations of bone filling in curettage defects

Authors: Clark J. Chen, Earl W. Brien

Published in: Journal of Orthopaedic Surgery and Research | Issue 1/2019

Login to get access

Abstract

Background

Curettage is widely used in orthopedic oncology; the defect created frequently requires filling for mechanical and functional stability for the bones and adjacent joint. Allograft, bone graft substitute, and polymethyl methacrylate (PMMA) are the most common substances used each with their benefits and drawbacks. The aim of the study is to show that good functional result can be achieved with curettage and bone filler, regardless of type.

Methods

A series of 267 cases were reviewed between 1994 and 2015 who received curettage treatment and placement of a bone filler. Endpoints included fracture, infection, cellulitis, pulmonary embolism, and paresthesia. Complication rates at our single institution were compared against literature values for three study cohorts: allograft, bone graft substitute, and PMMA bone fillers. Friedman test, Wilcoxon test, and Z-score for two populations were used to compare our subset against literature values and between different bone filling types.

Results

Our cases included 18 autografts, 74 allografts, 121 bone graft substitute, and 54 PMMA of which the bulk of complications occurred. Our overall complication rate was 3.37%. Allograft has a complication rate of 1.35%, bone graft substitute of 4.13%, and PMMA of 5.56%. Other techniques did not yield any complications. Combination filling techniques PMMA + allograft and PMMA + bone graft substitute had sample sizes too small for statistical comparison. Statistical comparison yielded no significant difference between complications in any of the filling groups (P = 0.411).

Conclusions

Some has even argued that bone defects following curettage do not require bone filling for good outcome. However, many structural or biologic benefits that aid in earlier return to functionality can be conferred by filling large bone defects. There was no significant difference in postoperative complication rates between allograft, bone graft substitute, and PMMA when compared at our institution and with literature values. Nevertheless, one complication with a large defect filled with allograft, requiring a subsequent reconstruction using vascularized fibular graft. Taking everything into account, we see bone graft substitute as a suitable alternative to other bone filling modalities.
Literature
1.
Piccioli A, Ventura A, Maccauro G, Spinelli MS, Del Bravo V, Rosa MA. Local adjuvants in surgical management of bone metastases. Int J Immunopathol Pharmacol. 2011;24(1 Suppl 2):129–32.PubMed
2.
Perisano C, Scaramuzzo L, De Santis V, Piccioli A, Ziranu A, Barone C, et al. Quality of life following surgical treatment of lower limb metastases in long bone. J Biol Regul Homeost Agents. 2015;29(2):501–7.PubMed
3.
Wu CC, Yu CT. Pure reconstruction with bone substitute pellets graft following curettage and high-speed burring for chondroblastoma of the proximal tibia: a case report and review of the literature. Orthop Surg. 2011;3(4):271–5.PubMedPubMedCentral
4.
Bauer RD, Lewis MM, Posner MA. Treatment of enchondromas of the hand with allograft bone. J Hand Surg Am. 1988;13(6):908–16.PubMed
5.
Kim JH, Oh JH, Han I, Kim HS, Chung SW. Grafting using injectable calcium sulfate in bone tumor surgery: comparison with demineralized bone matrix-based grafting. Clin Orthop Surg. 2011;3(3):191–201.PubMedPubMedCentral
6.
Zuo D, Zheng L, Sun W, Fu D, Hua Y, Cai Z. Contemporary adjuvant polymethyl methacrylate cementation optimally limits recurrence in primary giant cell tumor of bone patients compared to bone grafting: a systematic review and meta-analysis. World J Surg Oncol. 2013;11:156.PubMedPubMedCentral
7.
Guida P, Ragozzino R, Sorrentino B, Casaburi A, D’Amato RD, Federico G, et al. Three-in-One minimally invasive approach to surgical treatment of pediatric pathological fractures with wide bone loss through bone cysts: ESIN, curettage and packing with injectable HA bone substitute. A retrospective series of 116 cases. Injury. 2016;47(6):1222–8.PubMed
8.
Andreacchio A, Alberghina F, Testa G, Canavese F. Surgical treatment for symptomatic non-ossifying fibromas of the lower extremity with calcium sulfate grafts in skeletally immature patients. Eur J Orthop Surg Traumatol. 2018;28(2):291–7.PubMed
9.
Benevenia J, Rivero SM, Moore J, Ippolito JA, Siegerman DA, Beebe KS, et al. Supplemental bone grafting in giant cell tumor of the extremity reduces nononcologic complications. Clin Orthop Relat Res. 2017;475(3):776–83.PubMed
10.
Teng W, Lin P, Li Y, Yan X, Li H, Li B, et al. Bone combined cement grafting in giant cell tumor around the knee reduces mechanical failure. Int Orthop. 2019;43(2):475–82.PubMed
11.
Tomford WW. Transmission of disease through transplantation of musculoskeletal allografts. J Bone Joint Surg Am. 1995;77(11):1742–54.PubMed
12.
Mjoberg B, Pettersson H, Rosenqvist R, Rydholm A. Bone cement, thermal injury and the radiolucent zone. Acta Orthop Scand. 1984;55(6):597–600.PubMed
13.
Hirn M, de Silva U, Sidharthan S, Grimer RJ, Abudu A, Tillman RM, et al. Bone defects following curettage do not necessarily need augmentation. Acta Orthop. 2009;80(1):4–8.PubMedPubMedCentral
14.
Glancy GL, Brugioni DJ, Eilert RE, Chang FM. Autograft versus allograft for benign lesions in children. Clin Orthop Relat Res. 1991;262:28–33.
15.
Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol. 2005;23(27):6756–62.PubMed
16.
Levy DM, Gross CE, Garras DN. Treatment of unicameral bone cysts of the calcaneus: a systematic review. J Foot Ankle Surg. 2015;54(4):652–6.PubMed
17.
Hsu CC, Wang JW, Chen CE, Lin JW. Results of curettage and high-speed burring for chondroblastoma of the bone. Chang Gung Med J. 2003;26(10):761–7.PubMed
18.
Georgiannos D, Bisbinas I, Badekas A. Osteochondral transplantation of autologous graft for the treatment of osteochondral lesions of talus: 5- to 7-year follow-up. Knee Surg Sports Traumatol Arthrosc. 2016;24(12):3722–9.PubMed
19.
Chen W, Tang K, Yuan C, Zhou Y, Tao X. Intermediate results of large cystic medial osteochondral lesions of the talus treated with osteoperiosteal cylinder autografts from the medial tibia. Arthroscopy. 2015;31(8):1557–64.PubMed
20.
Gouin F, Dumaine V, French S. Bone Tumor Study Groups G-G. Local recurrence after curettage treatment of giant cell tumors in peripheral bones: retrospective study by the GSF-GETO (French Sarcoma and Bone Tumor Study Groups). Orthop Traumatol Surg Res. 2013;99(6 Suppl):S313–8.PubMed
21.
Badekas T, Takvorian M, Souras N. Treatment principles for osteochondral lesions in foot and ankle. Int Orthop. 2013;37(9):1697–706.PubMedPubMedCentral
22.
Ulucay C, Altintas F, Ozkan NK, Inan M, Ugutmen E. Surgical treatment for calcaneal intraosseous lipomas. Foot (Edinb). 2009;19(2):93–7.PubMed
23.
Yercan H, Ozalp T, Coskunol E, Ozdemir O. Long-term results of autograft and allograft applications in hand enchondromas. Acta Orthop Traumatol Turc. 2004;38(5):337–42.PubMed
24.
Lindner N, Brinkschmidt C, Suddendorf A, Rodl R, Gosheger G, Winkelmann W. Surgical reconstruction of fibrous dysplasia of bone in long-term follow-up. Z Orthop Ihre Grenzgeb. 2000;138(2):152–8.PubMed
25.
Gibbs CP Jr, Hefele MC, Peabody TD, Montag AG, Aithal V, Simon MA. Aneurysmal bone cyst of the extremities. Factors related to local recurrence after curettage with a high-speed burr. J Bone Joint Surg Am. 1999;81(12):1671–8.PubMed
26.
Chiang IM, Chen TH, Shih LY, Lo WH. Nonvascularized proximal fibular autograft to treat giant-cell tumor of the distal radius. Zhonghua Yi Xue Za Zhi (Taipei). 1995;56(5):331–7.PubMed
27.
Zbojniewicz AM, Sorger JI. Posttreatment imaging of pediatric musculoskeletal tumors. Radiographics. 2014;34(3):724–40.PubMed
28.
Aydin M, Togral G, Kekec F, Arikan M, Gungor S. Painful, pediatric sacral aneurysmal bone cyst treated by curettage and fresh frozen allograft. Eklem Hastalik Cerrahisi. 2016;27(2):103–7.PubMed
29.
Moretti VM, Slotcavage RL, Crawford EA, Lackman RD, Ogilvie CM. Curettage and graft alleviates athletic-limiting pain in benign lytic bone lesions. Clin Orthop Relat Res. 2011;469(1):283–8.PubMed
30.
Morii T, Yabe H, Morioka H, Suzuki Y, Anazawa U, Toyama Y. Curettage and allograft reconstruction for giant cell tumours. J Orthop Surg (Hong Kong). 2008;16(1):75–9.
31.
Muscolo DL, Ayerza MA, Calabrese ME, Gruenberg M. The use of a bone allograft for reconstruction after resection of giant-cell tumor close to the knee. J Bone Joint Surg Am. 1993;75(11):1656–62.PubMed
32.
Kang S, Han I, Hong SH, Cho HS, Kim W, Kim HS. The MRI appearances of cancellous allograft bone chips after the excision of bone tumours. Bone Joint J. 2015;97-B(1):121–8.PubMed
33.
Yang Y, Niu X, Zhang Q, Hao L, Ding Y, Xu H. A comparative study of calcium sulfate artificial bone graft versus allograft in the reconstruction of bone defect after tumor curettage. Chin Med J (Engl). 2014;127(17):3092–7.PubMed
34.
Lackman RD, Crawford EA, King JJ, Ogilvie CM. Conservative treatment of Campanacci grade III proximal humerus giant cell tumors. Clin Orthop Relat Res. 2009;467(5):1355–9.PubMed
35.
Ayerza MA, Aponte-Tinao LA, Farfalli GL, Restrepo CA, Muscolo DL. Joint preservation after extensive curettage of knee giant cell tumors. Clin Orthop Relat Res. 2009;467(11):2845–51.PubMedPubMedCentral
36.
Shih HN, Chen YJ, Huang TJ, Hsu KY, Hsu RW. Semistructural allografting in bone defects after curettage. J Surg Oncol. 1998;68(3):159–65.PubMed
37.
Sethi A, Agarwal K, Sethi S, Kumar S, Marya SK, Tuli SM. Allograft in the treatment of benign cystic lesions of bone. Arch Orthop Trauma Surg. 1993;112(4):167–70.PubMed
38.
Fillingham YA, Lenart BA, Gitelis S. Function after injection of benign bone lesions with a bioceramic. Clin Orthop Relat Res. 2012;470(7):2014–20.PubMedPubMedCentral
39.
Uchida A, Araki N, Shinto Y, Yoshikawa H, Kurisaki E, Ono K. The use of calcium hydroxyapatite ceramic in bone tumour surgery. J Bone Joint Surg Br. 1990;72(2):298–302.PubMed
40.
Saikia KC, Bhattacharya TD, Bhuyan SK, Talukdar DJ, Saikia SP, Jitesh P. Calcium phosphate ceramics as bone graft substitutes in filling bone tumor defects. Indian J Orthop. 2008;42(2):169–72.PubMedPubMedCentral
41.
Takeuchi A, Suwanpramote P, Yamamoto N, Shirai T, Hayashi K, Kimura H, et al. Mid- to long-term clinical outcome of giant cell tumor of bone treated with calcium phosphate cement following thorough curettage and phenolization. J Surg Oncol. 2018;117(6):1232–8.PubMed
42.
Rajeh MA, Diaz JJ, Facca S, Matheron AS, Gouzou S, Liverneaux P. Treatment of hand enchondroma with injectable calcium phosphate cement: a series of eight cases. Eur J Orthop Surg Traumatol. 2017;27(2):251–4.PubMed
43.
Rosario MS, Hayashi K, Yamamoto N, Takeuchi A, Miwa S, Taniguchi Y, et al. Functional and radiological outcomes of a minimally invasive surgical approach to monostotic fibrous dysplasia. World J Surg Oncol. 2017;15(1):1.PubMedPubMedCentral
44.
Sakamoto A. Reconstruction with beta-tricalcium phosphate for giant cell tumor of bone around the knee. J Knee Surg. 2017;30(1):75–7.PubMed
45.
Damron TA, Lisle J, Craig T, Wade M, Silbert W, Cohen H. Ultraporous beta-tricalcium phosphate alone or combined with bone marrow aspirate for benign cavitary lesions: comparison in a prospective randomized clinical trial. J Bone Joint Surg Am. 2013;95(2):158–66.PubMed
46.
Gentile JV, Weinert CR, Schlechter JA. Treatment of unicameral bone cysts in pediatric patients with an injectable regenerative graft: a preliminary report. J Pediatr Orthop. 2013;33(3):254–61.PubMed
47.
Seto S, Muramatsu K, Hashimoto T, Tominaga Y, Taguchi T. A new beta-tricalcium phosphate with uniform triple superporous structure as a filling material after curettage of bone tumor. Anticancer Res. 2013;33(11):5075–81.PubMed
48.
Reppenhagen S, Reichert JC, Rackwitz L, Rudert M, Raab P, Daculsi G, et al. Biphasic bone substitute and fibrin sealant for treatment of benign bone tumours and tumour-like lesions. Int Orthop. 2012;36(1):139–48.PubMed
49.
Van Hoff C, Samora JB, Griesser MJ, Crist MK, Scharschmidt TJ, Mayerson JL. Effectiveness of ultraporous beta-tricalcium phosphate (vitoss) as bone graft substitute for cavitary defects in benign and low-grade malignant bone tumors. Am J Orthop (Belle Mead NJ). 2012;41(1):20–3.PubMed
50.
El-Adl G, Mostafa MF, Enan A, Ashraf M. Biphasic ceramic bone substitute mixed with autogenous bone marrow in the treatment of cavitary benign bone lesions. Acta Orthop Belg. 2009;75(1):110–8.PubMed
51.
Hirata M, Murata H, Takeshita H, Sakabe T, Tsuji Y, Kubo T. Use of purified beta-tricalcium phosphate for filling defects after curettage of benign bone tumours. Int Orthop. 2006;30(6):510–3.PubMedPubMedCentral
52.
Matsumine A, Kusuzaki K, Matsubara T, Okamura A, Okuyama N, Miyazaki S, et al. Calcium phosphate cement in musculoskeletal tumor surgery. J Surg Oncol. 2006;93(3):212–20.PubMed
53.
Ogose A, Hotta T, Kawashima H, Kondo N, Gu W, Kamura T, et al. Comparison of hydroxyapatite and beta tricalcium phosphate as bone substitutes after excision of bone tumors. J Biomed Mater Res B Appl Biomater. 2005;72(1):94–101.PubMed
54.
Yamamoto T, Onga T, Marui T, Mizuno K. Use of hydroxyapatite to fill cavities after excision of benign bone tumours. Clinical results. J Bone Joint Surg Br. 2000;82(8):1117–20.PubMed
55.
Nicholas RW, Lange TA. Granular tricalcium phosphate grafting of cavitary lesions in human bone. Clin Orthop Relat Res. 1994;306:197–203.
56.
Capanna R, Manfrini M, Tigani D, Giunti A. Tricalcium phosphate and hydroxyapatite ceramics in the surgery of bone tumors: preliminary results. Chir Organi Mov. 1991;76(3):245–54.PubMed
57.
Muramatsu K, Tominaga Y, Hashimoto T, Taguchi T. Symptomatic intraosseous lipoma in the calcaneus. Anticancer Res. 2014;34(2):963–6.PubMed
58.
Hou HY, Wu K, Wang CT, Chang SM, Lin WH, Yang RS. Treatment of unicameral bone cyst: a comparative study of selected techniques. J Bone Joint Surg Am. 2010;92(4):855–62.PubMed
59.
Kelly CM, Wilkins RM. Treatment of benign bone lesions with an injectable calcium sulfate-based bone graft substitute. Orthopedics. 2004;27(1 Suppl):s131–5.PubMed
60.
Nakamura T, Matsumine A, Asanuma K, Matsubara T, Sudo A. Treatment of bone defect with calcium phosphate cement subsequent to tumor curettage in pediatric patients. Oncol Lett. 2016;11(1):247–52.PubMed
61.
Auston DA, Feibert M, Craig T, Damron TA. Unexpected radiographic lucency following grafting of bone defects with calcium sulfate/tricalcium phosphate bone substitute. Skeletal Radiol. 2015;44(10):1453–9.PubMed
62.
Friesenbichler J, Maurer-Ertl W, Sadoghi P, Pirker-Fruehauf U, Bodo K, Leithner A. Adverse reactions of artificial bone graft substitutes: lessons learned from using tricalcium phosphate geneX(R). Clin Orthop Relat Res. 2014;472(3):976–82.PubMed
63.
Chen G, Li J, Li X, Fan H, Guo Z, Wang Z. Giant cell tumor of axial vertebra: surgical experience of five cases and a review of the literature. World J Surg Oncol. 2015;13:62.PubMedPubMedCentral
64.
Malawer MM, Chou LB. Prosthetic survival and clinical results with use of large-segment replacements in the treatment of high-grade bone sarcomas. J Bone Joint Surg Am. 1995;77(8):1154–65.PubMed
65.
Malawer MM, Marks MR, McChesney D, Piasio M, Gunther SF, Schmookler BM. The effect of cryosurgery and polymethylmethacrylate in dogs with experimental bone defects comparable to tumor defects. Clin Orthop Relat Res. 1988;226:299–310.
66.
Xing R, Yang J, Kong Q, Tu C, Zhou Y, Duan H. Giant cell tumour of bone in the appendicular skeleton: an analysis of 276 cases. Acta Orthop Belg. 2013;79(6):731–7.PubMed
67.
van der Heijden L, van de Sande MA, Heineken AC, Fiocco M, Nelissen RG, Dijkstra PD. Mid-term outcome after curettage with polymethylmethacrylate for giant cell tumor around the knee: higher risk of radiographic osteoarthritis? J Bone Joint Surg Am. 2013;95(21):e159.PubMed
68.
Di Giorgio L, Touloupakis G, Vitullo F, Sodano L, Mastantuono M, Villani C. Intralesional curettage, with phenol and cement as adjuvants, for low-grade intramedullary chondrosarcoma of the long bones. Acta Orthop Belg. 2011;77(5):666–9.PubMed
69.
Gaston CL, Bhumbra R, Watanuki M, Abudu AT, Carter SR, Jeys LM, et al. Does the addition of cement improve the rate of local recurrence after curettage of giant cell tumours in bone? J Bone Joint Surg Br. 2011;93(12):1665–9.PubMed
70.
Wada T, Kaya M, Nagoya S, Kawaguchi S, Isu K, Yamashita T, et al. Complications associated with bone cementing for the treatment of giant cell tumors of bone. J Orthop Sci. 2002;7(2):194–8.PubMed
71.
Bickels J, Wittig JC, Kollender Y, Kellar-Graney K, Mansour KL, Meller I, et al. Enchondromas of the hand: treatment with curettage and cemented internal fixation. J Hand Surg Am. 2002;27(5):870–5.PubMed
72.
Yildiz Y, Bayrakci K, Altay M, Saglik Y. The use of polymethylmethacrylate in the management of hydatid disease of bone. J Bone Joint Surg Br. 2001;83(7):1005–8.PubMed
73.
Dunne NJ, Orr JF. Curing characteristics of acrylic bone cement. J Mater Sci Mater Med. 2002;13(1):17–22.PubMed
74.
Malek F, Krueger P, Hatmi ZN, Malayeri AA, Faezipour H, O’Donnell RJ. Local control of long bone giant cell tumour using curettage, burring and bone grafting without adjuvant therapy. Int Orthop. 2006;30(6):495–8.PubMedPubMedCentral
Metadata
Title
Early postoperative compilations of bone filling in curettage defects
Authors
Clark J. Chen
Earl W. Brien
Publication date
01-12-2019
Publisher
BioMed Central
Published in
Journal of Orthopaedic Surgery and Research / Issue 1/2019
Electronic ISSN: 1749-799X
DOI
https://doi.org/10.1186/s13018-019-1297-4

Other articles of this Issue 1/2019

Journal of Orthopaedic Surgery and Research 1/2019 Go to the issue

Research article

Does lumbar lordosis minus thoracic kyphosis predict the clinical outcome of patients with adult degenerative scoliosis?

Research article

Percutaneous kyphoplasty assisted with/without mixed reality technology in treatment of OVCF with IVC: a prospective study

Technical note

Endoscopic transnasal anterior release and posterior reduction without odontoidectomy for irreducible atlantoaxial dislocation

Systematic review

Risk factors associated with cardiac complication after total joint arthroplasty of the hip and knee: a systematic review

Research article

Application of fracture-sustaining reduction frame in closed reduction of femoral shaft fracture

Research article

The 10-year outcomes of the ASR XL Acetabular System: a single-center experience from China